Pretreatment with Oleuropein Protects the Neonatal Brain from Hypoxia-ischemia by Inhibiting Apoptosis and Neuroinflammation

Hypoxic-ischemic (HI) encephalopathy is a cerebrovascular injury caused by oxygen deprivation to the brain and remains a major cause of neonatal mortality and morbidity worldwide. Therapeutic hypothermia is the current standard of care but it does not provide complete neuroprotection. Our aim was to...

Descripción completa

Detalles Bibliográficos
Autores: Reyes Corral, Marta, Gil González, Laura, González Díaz, Ángela, Tovar Luzón, Javier, Ayuso, María Irene, Lao Pérez, Miguel, Montaner, Joan, Puerta Vázquez, Rocío de la, Fernández Torres, Rut, Ybot González, Patricia
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/162962
Acceso en línea:https://hdl.handle.net/11441/162962
https://doi.org/10.1177/0271678X241270237
Access Level:acceso abierto
Palabra clave:Microglia
Neonatal hypoxia-ischemia
Neuroprotection
Oleuropein
White matter injury
Descripción
Sumario:Hypoxic-ischemic (HI) encephalopathy is a cerebrovascular injury caused by oxygen deprivation to the brain and remains a major cause of neonatal mortality and morbidity worldwide. Therapeutic hypothermia is the current standard of care but it does not provide complete neuroprotection. Our aim was to investigate the neuroprotective effect of oleuropein (Ole) in a neonatal (seven-day-old) mouse model of HI. Ole, a secoiridoid found in olive leaves, has previously shown to reduce damage against cerebral and other ischemia/reperfusion injuries. Here, we administered Ole as a pretreatment prior to HI induction at 20 or 100 mg/kg. A week after HI, Ole significantly reduced the infarct area and the histological damage as well as white matter injury, by preserving myelination, microglial activation and the astroglial reactive response. Twenty-four hours after HI, Ole reduced the overexpression of caspase-3 and the proinflammatory cytokines IL-6 and TNF-α. Moreover, using UPLC-MS/MS we found that maternal supplementation with Ole during pregnancy and/or lactation led to the accumulation of its metabolite hydroxytyrosol in the brains of the offspring. Overall, our results indicate that pretreatment with Ole confers neuroprotection and can prevent HI-induced brain damage by modulating apoptosis and neuroinflammation.